• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Monogram Biosciences Announces 4Q 2008 Financial Results
 

Monogram Biosciences Announces 4Q 2008 Financial Results

on

  • 1,951 views

Monogram Biosciences Announces 4Q 2008 Financial Results

Monogram Biosciences Announces 4Q 2008 Financial Results

Statistics

Views

Total Views
1,951
Views on SlideShare
1,951
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Monogram Biosciences Announces 4Q 2008 Financial Results Monogram Biosciences Announces 4Q 2008 Financial Results Document Transcript

    • Monogram Biosciences Announces Fourth Quarter 2008 Financial Results Conference Call SOUTH SAN FRANCISCO, Calif., Jan 30, 2009 (BUSINESS WIRE) -- Monogram Biosciences, Inc., (Nasdaq:MGRM) announced that it will hold a conference call on Thursday, February 12, 2009 at 4:30 p.m. (Eastern Time) to discuss fourth quarter 2008 financial results. The call will be hosted by Mr. William D. Young, Chairman and CEO of Monogram. To participate in the live teleconference, please call (877) 719-9796, or (719) 325-4801 for international callers, fifteen minutes before the conference begins. Live audio of the call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. Following the live broadcast, a replay of the call will also be available beginning at 9:30 p.m. (Eastern Time) at (888) 203-1112, or (719) 457-0820 for international callers, until 11:59 p.m. (Eastern Time) on Sunday, February 22, 2009. The replay passcode is 9724774. Access to live and archived audio of the conference call will be available by following the appropriate links at www.monogrambio.com and clicking on the Investor Relations link. The information provided on the teleconference is only accurate at the time of the conference call, and Monogram will take no responsibility for providing updated information except as required by law. About Monogram Biosciences, Inc. Monogram is advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at www.monogrambio.com. SOURCE: Monogram Biosciences, Inc. Monogram Biosciences, Inc. Alfred G. Merriweather, 650-624-4576 Chief Financial Officer amerriweather@monogrambio.com or Feinstein Kean Healthcare Jeremiah Hall, 415-677-2700 jeremiah.hall@fkhealth.com Copyright Business Wire 2009